In conclusion, we show here that treatment with the ACCi firsocostat significantly increases the synthesis rate of apoB-containing LDL particles in NASH subjects with cirrhosis, without a significant increase in plasma apoB concentrations (Graphical abstract). Here, APOB is linked to Cirrhosis.